CAS: 142-55-2; 2-Hydroxypropyl Dodecanoate

该化合物是一种合成酯,产自多德诺酸和丙烯丙烯丙醇.这种复合物在极地溶剂和非极地溶剂中都表现出有利的溶解性,使其成为工业应用中的多用途中间体.其化学结构提供了更稳定的低挥发性,适合于润滑剂,增塑剂和化妆品配方.该酯的氢氧基组可以进一步功能化,扩大其在特殊化学合成中的用途.此外,它显示了良好的生物降解性和温和皮肤的兼容性,符合环境意识的配方. 它的平衡的水利和亲利性使它在多阶段系统中作为乳化剂或溶剂有效.

结构式图片

相似化合物

7249-54-9 1330-80-9 58921-10-1

上下游产品

CAS号57-55-6 丙二醇 | CAS号645-66-9 月桂酸酐

合成工艺路线路线简述

    📜月桂酸,1,3-丙二醇置于氨体系中,化学反应 6.0H,反应生成1,2-丙二醇单十二酸酯
    参考文献:一种月桂酸丙二醇酯型抗磨剂的制备方法
    标题:一种月桂酸丙二醇酯型抗磨剂的制备方法
    摘要:本发明属于润滑剂技术领域,具体涉及一种月桂酸丙二醇酯型抗磨剂的制备方法,以月桂酸和1,3‑丙二醇为原料,将月桂酸,1,3‑丙二醇加入到四口烧瓶中,再加入催化剂h‑732阳离子交换树脂,通入氮气,反应温度控制在100oc~110°C,反应过程中每隔1H测产物的酸值,直至酸值小于1Mg Koh/g,反应结束.本发明合成产物具有非常好的抗磨性能,催化剂可重复利用.

    海关参考信息

    专利信息


    专利号:US-2024082118-A1
    优先权日:2021-05-19
    标 题:Topical compositions and methods of preparing the same
    发明人:ABRAMOVICH SAGI; AVIDOR GAL; LANDA BENZION
    权利人:LANDA LABS 2012 LTD
    摘要:There is disclosed a composition comprising a water-insoluble thermoplastic compound capable of stimulating collagen synthesis (CSSC), the CSSC having a molecular weight of more than 0.6 kDa and being dispersed in a polar carrier as nano-elements having an average diameter of 200 nm or less and a viscosity of 107 mPa·s or less. The nano-elements of CSSC can be capable of stimulating the synthesis of skin proteins and/or enabling the delivery of active agents upon their application to a surface to be treated therewith. Methods for preparing the compositions and uses thereof are also provided.

    专利号:WO-2004087679-A1
    优先权日:2003-04-01
    标 题 :2, 4, 6-trisubstituted pyrimidine derivatives useful for the treatment of neoplastic and autoimmune diseases
    发明人:OBRECHT DANIEL; ERMERT PHILIPP; LUTHER ANATOL; EBERLE MARTIN; BACHMANN FELIX
    权利人:APONETICS AG; OBRECHT DANIEL; ERMERT PHILIPP; LUTHER ANATOL; EBERLE MARTIN; BACHMANN FELIX
    摘要:The invention relates to substituted pyrimidines of formula (I) wherein V represents a bond or CR6R7, W represents a bond, NR8 or oxygen, X represents sulfur, or nitrogen substituted by hydrogen or R5, Y represents -CH2-, -CH2CH2-, -CO- or -CS-, R1 represents unsubstituted or substituted aryl or heteroaryl, and the substituents R2, R3, R4, R5, R6, R7 and R8 have the meanings given in the specification. These compounds are selectively inducing apoptosis in cancer cells and can be used for the treatment of neoplastic and autoimmune diseases. The invention relates also to methods of synthesis of such compounds, to their use as medicaments, to pharmaceutical compositions containing same, and to methods of treatment of neoplastic and autoimmune diseases using such compounds of formula (I) or of pharmaceutical compositions containing same.

    专利号:US-12295961-B2
    优先权日:2009-12-31
    标 题:Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols
    发明人:DHINGRA OM
    权利人:MARIUS PHARMACEUTICALS INC
    摘要:A formulation for drug delivery, providing enhanced modulation of solubility, stability, absorption, metabolism, and/or pharmacokinetic profile of a lipophilic therapeutic agent by formulation with sterols and/or sterol esters, resulting in higher bioavailability of a therapeutic agent administered to a subject in need of such therapeutic agent. The formulation contains a therapeutic agent and a sterol or sterol ester, and can, optionally, further contain a solubilizer and/or an enhancing agent. Also described are pharmaceutical compositions containing the formulations and methods of making and methods of using the formulations and pharmaceutical compositions. Formulations of the disclosure can be constituted to minimize the synthesis of dihydrotestosterone when the therapeutic agent includes testosterone or testosterone esters.

    专利号:US-11850220-B2
    优先权日:2020-05-19
    标题 :Synthesis of ibuprofen hybrid conjugates as anti-inflammatory and analgesic agents
    发明人:PANDA SIVA
    权利人:UNIV RES INST INC AUGUSTA
    摘要:Disclosed herein as ibuprofen hybrid conjugates and methods of their use to reduce inflammation, pain, and fever. The ibuprofen conjugates have potent anti-inflammatory and analgesic properties with low potential for ulcerogenic activity. An exemplary compound is an ibuprofen-amino acid-4-aminophenol hybrid. Also disclosed are methods of treating or reducing inflammation, pain, and fever in a subject.

    专利号:US-2022370393-A1
    优先权日:2019-10-16
    标 题 :Method and composition for increasing muscle protein synthesis
    发明人:BELLAMINE AOUATEF; GLAB STANISLAW; DURKEE SHANE
    权利人:CAPSUGEL BELGIUM NV
    摘要:A method and composition for increasing muscle protein synthesis in mammals is disclosed. In one embodiment, the mammals are administered a protein building composition comprising at an amino acid derivative including L-carnitine and a nitrogenous organic acid including creatine. In a particular embodiment, the creatine is in an acid resistant capsule delivery form. The ratio of L-carnitine to creatine can be from about 10:1 to about 1:1. The protein building composition can be administered in a monolithic enteric capsule.

    专利号:US-2022370392-A1
    优先权日:2019-10-16
    标 题:Method and Composition for Increasing Muscle Protein Synthesis
    发明人:BELLAMINE AOUATEF; GLAB STANISLAW; DURKEE SHANE
    权利人:BELLAMINE AOUATEF; CAPSUGEL BELGIUM NV
    摘要:A method and composition for increasing muscle protein synthesis in mammals is disclosed. In one embodiment, the mammals are administered a protein building composition comprising at an amino acid component including L-carnitine and a nitrogenous organic acid including creatine. In a particular embodiment, the creatine is in a solution with L-carnitine. The ratio of L-carnitine to creatine can be from about 10:1 to about 1:1. The protein building z composition can be administered in a monolithic enteric capsule.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:S13 | EUCOSMETICS | Combined Inventory of Ingredients Employed in Cosmetic Products (2000) and Revised Inventory (2006) | DOI:10.5281/zenodo.2624118
    摘要:Final Report 12/2014 Available from CIR
    摘要:International Journal of Toxicology 18(S2):35-52, 1999
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知